Mutations in dynamin 2 cause dominant centronuclear myopathy

@article{Bitoun2005MutationsID,
  title={Mutations in dynamin 2 cause dominant centronuclear myopathy},
  author={Marc Bitoun and Svetlana Maugenre and P. Y. Jeannet and Emmanuelle Lac{\`e}ne and Xavier Ferrer and Pascal Lafor{\^e}t and Jean-Jacques Martin and Jocelyn Laporte and Hanns Lochm{\"u}ller and Alan H. Beggs and Michel Gustave Jules Fardeau and Bruno Eymard and Norma B Romero and Pascale Guicheney},
  journal={Nature Genetics},
  year={2005},
  volume={37},
  pages={1207-1209}
}
Autosomal dominant centronuclear myopathy is a rare congenital myopathy characterized by delayed motor milestones and muscular weakness. In 11 families affected by centronuclear myopathy, we identified recurrent and de novo missense mutations in the gene dynamin 2 (DNM2, 19p13.2), which encodes a protein involved in endocytosis and membrane trafficking, actin assembly and centrosome cohesion. The transfected mutants showed reduced labeling in the centrosome, suggesting that DNM2 mutations might… 

Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset

Dominant Centronuclear Myopathy with Early Childhood Onset due to a Novel Mutation in BIN1.

A Dutch family with AD CNM due to a novel BIN1 mutation strongly impairing the membrane tubulation activity of amphiphysin-2 was reported, with the main features being mild proximal weakness with pronounced myalgia, exercise intolerance and large muscle mass.

Dynamin 2 the rescue for centronuclear myopathy.

DNM2 regulates membrane trafficking through vesicular scission, and it is presumed that reducing this activity accounts for improved outcome in X-linked centronuclear myopathy.

Large duplication in MTM1 associated with myotubular myopathy

RYR1 mutations are a common cause of congenital myopathies with central nuclei

This work investigated whether RYR1 mutations cause CNM, a rare congenital myopathy characterized by prominence of central nuclei on muscle biopsy that has been associated with mutations in MTM1, DNM2, and BIN1.

X-linked myotubular myopathy due to a complex rearrangement involving a duplication of MTM1 exon 10

Adult- Onset Centronuclear Myopathy.

A 50 year old male patient with centronuclear myopathy (CNM) in whom the disease manifested itself in the fifth decade of life without any family history of such illness is reported.

Novel SPEG mutations in congenital myopathies: Genotype–phenotype correlations

2 additional patients with SPEG mutations with muscle weakness expanding the phenotype are reported, and genotype–phenotype correlations associated withSPEG mutations are evaluated.

Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy

...

References

SHOWING 1-10 OF 14 REFERENCES

Clinical and histologic findings in autosomal centronuclear myopathy

The classification reported in this study will be useful for the diagnosis and the follow-up evaluation of patients with autosomal CNM and for the research into the molecular defects underlying the condition.

Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease

Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of peripheral neuropathies. Different chromosomal loci have been linked with three autosomal dominant,

Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.

An analysis of the myotubularin family in sequenced genomes finds that phosphoinositides are signaling molecules that are notably involved in vacuolar transport and membrane trafficking and are proposed to be implicated in these cellular mechanisms.

Myotubular myopathy. Persistence of fetal muscle in an adolescent boy.

Clinical, pathological, cytochemical, and electron microscopic studies of gastrocnemius muscle disease are presented and an attempt will also be made to correlate these findings with previously reported studies in myogenesis.

Dynamin 2 binds γ-tubulin and participates in centrosome cohesion

Fluorescence recovery after photobleaching (FRAP) analysis of a GFP-tagged Dyn2 middle domain indicated that Dyn2 is a dynamic exchangeable component of the centrosome, suggesting a novel function for Dyn2 as a participant in Centrosome cohesion.

The dynamin superfamily: universal membrane tubulation and fission molecules?

It is proposed that a common mechanism leading to membrane tubulation and/or fission could encompass their many varied functions.

Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues.

Results indicate that dynamin proteins are encoded by at least two genes expressed differentially in mammalian tissues and that the expression of Dyn2, and not of brain dynamin, accounts for the ubiquitous distribution of dynamin in rat tissues.

Fate of microtubule-organizing centers during myogenesis in vitro

In myoblasts, the authors observed a classical microtubule network centered on juxtanuclear centrosomes, and in myotubes, this phenomenon appears to be specific to myogenic differentiation.

Dynamin II interacts with syndecan-4, a regulator of focal adhesion and stress-fiber formation.

The stalk region of dynamin drives the constriction of dynamin tubes

The nonconstricted state of mutant dynamin is solved by a single-particle approach and it is shown that the stalk region of dynamin undergoes a large conformational change that drives tube constriction.